Study: Triple Neg Breast Cancer Therapy Announced

0
315

DB: Combining an existing drug with chemotherapy can suppress an aggressive type of breast cancer’s resurgence, a study published Tuesday found.

The study, published in The New England Journal of Medicine, found that treating patients with both Keytruda, an immunotherapy drug, and chemotherapy prior to surgery reduced the chances of disease recurrence for early triple-negative breast cancer by 37 percent when compared with patients treated solely with chemotherapy.

Lead researcher Peter Schmid, a professor at Queen Mary University of London, said, “The estimates are that, just in the US where this treatment was recently approved by the Food and Drug Administration, this new treatment may save as many as 10,000 lives per year.”

https://www.thedailybeast.com/keytruda-and-chemotherapy-could-save-thousands-from-breast-cancer-study-finds?ref=home



ATTENTION READERS

We See The World From All Sides and Want YOU To Be Fully Informed
In fact, intentional disinformation is a disgraceful scourge in media today. So to assuage any possible errant incorrect information posted herein, we strongly encourage you to seek corroboration from other non-VT sources before forming an educated opinion.

About VT - Policies & Disclosures - Comment Policy
Due to the nature of uncensored content posted by VT's fully independent international writers, VT cannot guarantee absolute validity. All content is owned by the author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners, or technicians. Some content may be satirical in nature. All images are the full responsibility of the article author and NOT VT.